E. V. . Saenz, A. . Golibkhon, and Y. . Ibragim, “A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease”, Journal of Prevention, Diagnosis and Management of Human Diseases, vol. 3, no. 02, pp. 1–8, Jul. 2023.